LCDActive
Repetitive Transcranial Magnetic Stimulation (rTMS) in Adults
L34869
Effective: January 16, 2025
Updated: December 31, 2025
Policy Summary
Outpatient rTMS is covered for adults (>=18) with DSM-5 defined severe Major Depressive Disorder or OCD who have failed or cannot tolerate adequate trials of psychopharmacologic agents and have not improved after evidence-based psychotherapy, with treatment ordered and supervised by an experienced psychiatrist. Contraindications include seizure disorders, active psychotic disorders in the current episode, certain neurological conditions, and implanted magnetic-sensitive devices within 30 cm of the coil; all other uses are experimental and not covered.
Coverage Criteria Preview
Key requirements from the full policy
"Adult (age >=18) with a confirmed DSM-5 diagnosis of severe Major Depressive Disorder (single or recurrent) is a candidate for left prefrontal rTMS when other coverage criteria are met."
Sign up to see full coverage criteria, indications, and limitations.